Selection of Therapeutic Agents for Intraocular Proliferative Disease
Authors:
- Mark S. BlumenkranzMBMark S. Blumenkranz
- Michael K. HartzerMHMichael K. Hartzer
- Anthony S. HajekAHAnthony S. Hajek
- 1 March 1987
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 105 (3) , 396-399
Abstract
Research from JAMA Ophthalmology — Selection of Therapeutic Agents for Intraocular Proliferative Disease — II. Differing Antiproliferative Activity of the FluoropyrimidinesKeywords
This publication has 12 references indexed in Scilit:
- Fluorouracil for the Treatment of Massive Periretinal ProliferationAmerican Journal of Ophthalmology, 1982
- Studies on a new class of potential antiangiogenic agents: Nucleoside antimetabolite drugsMicrovascular Research, 1981
- GROWTH-CHARACTERISTICS AND ULTRASTRUCTURE OF HUMAN RETINAL-PIGMENT EPITHELIUM INVITRO1980
- Intraocular Penetration of Subconjunctivally Administered 14C-Fluorouracil in RabbitsArchives of Ophthalmology (1950), 1979
- EFFECT OF 5-FLUOROURACIL ON THE SYNTHESIS AND TRANSLATION OF POLYADENYLIC ACID-CONTAINING RNA FROM REGENERATING RAT-LIVER1979
- Pharmacokinetics of 5-FluorouracilClinical Pharmacokinetics, 1977
- Biological consequences of incorporation of 5-fluorocytidine in the RNA of 5-fluorouracil-treated eukaryotic cells.Proceedings of the National Academy of Sciences, 1976
- The metabolism and pharmacology of 5‐fluorouracilJournal of Surgical Oncology, 1971
- Fluorinated Pyrimidines1965
- STUDIES ON FLUORINATED PYRIMIDINES .8. FURTHER BIOCHEMICAL AND METABOLIC INVESTIGATIONS1959